News

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...
For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can ...
Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.
Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...